Related Experiment Videos
[Speed of intubation using a new neuromuscular blocker. Rocuronium bromide (ORG 9426)]
J A Alvarez-Gómez1, J Fabregat, M E Estellés
1Unidad de Investigación Area II, Hospital Rosell, Cartagena.
Revista Espanola De Anestesiologia Y Reanimacion
|January 1, 1994
Summary
Rocuronium bromide offers faster intubation conditions compared to vecuronium and atracurium. This neuromuscular blocker provides excellent intubating conditions rapidly, potentially improving anesthetic practice.
Area of Science:
- Anesthesiology
- Pharmacology
- Critical Care Medicine
Background:
- Neuromuscular blocking agents are essential in modern anesthesia.
- Optimizing intubation conditions and onset of action is crucial for patient safety.
- Rocuronium bromide is a newer agent with a distinct pharmacokinetic profile.
Purpose of the Study:
- To compare intubation conditions and neuromuscular parameters of rocuronium bromide (ORG 9426) against vecuronium and atracurium.
- Evaluate onset time, duration of effect, and clinical efficacy.
- Assess safety and hemodynamic stability during administration.
Main Methods:
- A randomized study involving sixty patients divided into three groups.
- Intubation conditions assessed using a standardized scale (3-12 points).
- Neuromuscular blockade monitored via electromyography and train-of-four stimulation.
Main Results:
- Rocuronium demonstrated significantly faster onset times (33 sec) and time to effect (135 sec) compared to vecuronium and atracurium.
- Excellent intubation conditions were achieved with rocuronium at 60 seconds, though peripheral block was partial.
- Clinical duration and hemodynamic stability were similar across all groups.
Conclusions:
- Rocuronium bromide provides rapid intubation conditions, potentially superior to existing agents.
- Its speed of action offers a significant advantage in anesthetic procedures.
- Further research may confirm rocuronium's role in optimizing airway management.